Maintaining funding for global health programs will ensure success

"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin -- chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece. "At this unique moment in time -- where we have an opportunity to truly turn the tide on diseases like AIDS, tuberculosis and malaria -- having a strong advocate, such as the one we have in Secretary of State John Kerry, has never been more critical," he continues. "Like Secretary Kerry, I, too, have met people on the front lines of fighting these diseases," Chernin writes, adding, "My experiences, and the knowledge I have gained from them, inform my excitement about Secretary Kerry and his record of supporting lifesaving health efforts worldwide."

"In the past decade, strong political champions and increases in funding have helped to avert 1.1 million malaria deaths, reduce the number of new tuberculosis cases, and ensure AIDS treatment for more than eight million people worldwide," Chernin notes and highlights examples of successes in fighting the diseases. "This kind of progress is due in large part to the support of individuals like Secretary Kerry and the efforts of organizations like the Global Fund," as well as "[t]he U.S. government's endorsement of and support for the Global Fund," which "allow[s] the organization to work hand-in-hand with bilateral initiatives, such as the President's Malaria Initiative and PEPFAR," he states. "It is clear that [Kerry] understands that global health is not a one-time investment," Chernin continues, concluding, "By maintaining funding today, we have the opportunity to stop these diseases in their tracks and continue building upon the successes of the past decade, rather than risk squandering the investments we've made thus far" (3/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption